Thermo Fisher (TMO +4.8%) gains after its Q3 beats consensus estimates. Net profit rose 9.4%...


Thermo Fisher (TMO +4.8%) gains after its Q3 beats consensus estimates. Net profit rose 9.4% Y/Y, as the supplier of analytical technologies and laboratory products posted stronger-than-expected revenue growth. The company also raised its FY12 estimate above Street estimates, to between $4.81 and $4.88 a share on revenue of $12.3B to $12.4B.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs